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Abstract
Background: Studies on the associations between smoking and allergic diseases have mostly focused on asthma.
Epidemiological studies in adults on the effects of smoking on allergic diseases other than asthma, such as eczema
and rhinoconjunctivitis, have been limited, and the information that is available has been inconsistent. The aim of
this study was to investigate the association between smoking status and environmental tobacco smoke (ETS)
exposure and the prevalence of allergic diseases.
Methods: Study subjects were 1743 pregnant Japanese women. The definitions of wheeze and asthma were
based on criteria from the European Community Respiratory Health Survey whereas those of eczema and
rhinoconjunctivitis were based on criteria from the International Study of Asthma and Allergies in Childhood.
Adjustment was made for age; region of residence; family history of asthma, atopic eczema, and allergic rhinitis;
household income; and education.
Results: Compared with never smoking, current smoking and ≥ 4 pack-years of smoking were independently
positively associated with the prevalence of wheeze. There were no associations between smoking status and the
prevalence of asthma, eczema, or rhinoconjunctivitis. When subjects who had never smoked were classified into
four categories based on the source of ETS exposure (never, only at home, only at work, and both), exposure
occurring both at home and at work was independently associated with an increased prevalence of two
outcomes: wheeze and rhinoconjunctivitis. No relationships were observed between exposure to ETS and the
prevalence of asthma or eczema.
Conclusions: Our results provide evidence that current smoking and ETS exposure may increase the likelihood of
wheeze. The possibility of a positive association between ETS exposure and rhinoconjunctivitis was also suggested.
Keywords: Asthma, Cross-sectional studies, Eczema, Environmental tobacco smoke, Smoking, Wheeze,
Rhinoconjunctivitis
Introduction
Cigarette smoking is a known risk factor for various
neurological, cardiovascular, and pulmonary diseases
such as chronic obstructive pulmonary disease and lung
cancer [1]. Research on the association between smok-
ing and allergic diseases has mostly focused on asthma,
and most evidence suggests that smoking is positively
associated with asthma [2-6]. A population-based cohort
study in Japan has shown that smoking is significantly
associated with an increased risk of asthma in men,
though this significant positive association was not
observed in women [2]. Moreover, in the National
Health and Nutrition Examination (USA), no association
was observed between current smoking and asthma [6].
Epidemiological studies in adults on the effects of smok-
ing on allergic diseases other than asthma, such as
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[7-12].
Evidence of the adverse health effects of exposure to
environmental tobacco smoke (ETS) has recently been
accumulating. Most publications on ETS exposure have
focused on respiratory symptoms and asthma among
children. Evidence concerning the relationship between
ETS and allergic diseases in adults has been limited and
has provided contradictory results [13-21]. A prospective
study among non-smoking young adults in Canada has
shown no association between ETS exposure and the
risk of wheeze [13]. In a cross-sectional study among
never-smoking Italian women, on the other hand, expo-
sure to ETS was positively associated with the preva-
lence of wheeze, asthma, and rhinoconjunctivitis [14].
Assessment of the results of exposure to ETS might be
more complex in adults than in children, because adults
are exposed to ETS from multiple sources, such as the
home, the workplace, and public places [22].
In short, the literature on the association between
smoking and allergic diseases in adults has yielded het-
erogeneous findings. In the present study, we investi-
gated whether smoking status and exposure to ETS at
home and at work was associated with a higher preva-
lence of wheeze, asthma, eczema, and rhinoconjunctivi-
tis among pregnant Japanese women, using the baseline
data set of the Kyushu Okinawa Maternal and Child
Health Study (KOMCHS).
Methods
Study population
The KOMCHS is an ongoing prospective birth cohort
study that investigates preventive and risk factors for
maternal and child health problems such as allergic dis-
orders. The background and general procedure of the
KOMCHS have been described previously [23,24]. In
brief, the KOMCHS requested that pregnant women
complete a baseline survey, which was followed by sev-
eral post-natal surveys. Eligible subjects were those
women who became pregnant in one of seven prefec-
tures on Kyushu Island in southern Japan or Okinawa
Prefecture between April 2007 and March 2008. At 423
obstetric hospitals, a set of leaflets explaining the
KOMCHS, an application form to participate in the
study, and a self-addressed and stamped return envelope
were distributed to pregnant women, insofar as this was
possible. Pregnant women who intended to participate
in the KOMCHS returned the application form to the
data management center. In the end, a total of 1757
pregnant women between the 5th and 39th week of
pregnancy gave their fully informed consent in writing
to participate and completed the baseline survey.
Excluded were 14 pregnant women because of missing
data on the factors under study, leaving data on 1743
pregnant women available for analysis. The ethics com-
mittee of the Faculty of Medicine, Fukuoka University,
approved the KOMCHS.
Measurements
In the baseline survey, each participant filled out a set of
2 self-administered questionnaires. Participants mailed
the answered questionnaires to the data management
center. Research technicians completed missing or illogi-
cal data by telephone interview.
One of the self-administered questionnaires included
questions on wheeze and asthma based on the European
Community Respiratory Health Survey [25] and questions
on eczema and rhinoconjunctivitis based on the Interna-
tional Study of Asthma and Allergies in Childhood
[26,27]. Wheeze was defined as a positive response to the
question, ‘Have you had wheezing or whistling in your
chest at any time in the last 12 months?’ Asthma was
defined as a positive response to either of 2 situations: an
asthma attack during the last 12 months or current use of
asthma medication. Affirmative answers to the following 3
questions were required to indicate the presence of
eczema: ‘Have you ever had an itchy rash which was com-
ing and going for at least 6 months?’, ‘Have you had this
itchy rash at any time in the last 12 months?’ and ‘Has this
itchy rash at any time affected any of the following places:
the folds of the elbows, behind the knees, in front of the
ankles, under the buttocks, or around the neck, ears, or
eyes?’ Rhinoconjunctivitis was defined as present by a
positive response to the following 2 questions: ‘In the last
12 months, have you had a problem with sneezing or a
runny or blocked nose when you did not have a cold or
flu?’ and ‘In the last 12 months, has this nose problem
been accompanied by itchy-watery eyes?’ The question-
naire also elicited information on age, smoking habits,
ETS exposure at home and at work, family history of
asthma, atopic eczema, and allergic rhinitis, household
income, and education. Cumulative exposure to cigarette
smoking was summarized by multiplying the average
number of packs smoked per day (cigarettes smoked per
day divided by 20) by the number of years smoked (pack-
years of smoking), regardless of whether smoking status
w a sf o r m e ro rc u r r e n t .E x p o s u r et oE T Sa th o m ea n da t
work was assessed by the questions “Have you ever been
exposed to smoke from family members at home?” and
“Have you ever been exposed to smoke at your work-
place?” A family history of asthma, atopic eczema, or aller-
gic rhinitis (including Japanese cedar pollinosis) was
considered to be present if one or more parents or siblings
of the study subjects had been diagnosed by a physician as
having any of these allergic disorders.
The second questionnaire was a validated self-admi-
nistered diet history questionnaire. Data regarding diet
were not used in the present study.
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Age; region of residence; family history of asthma, atopic
eczema, and allergic rhinitis; household income; and
education were a priori selected as potential confound-
ing factors. Region of residence was classified into 3
categories (Fukuoka Prefecture, other than Fukuoka Pre-
fecture on Kyushu Island, and Okinawa Prefecture),
household income into 3 (< 4,000,000, 4,000,000 -
5,999,999, and ≥ 6,000,000 yen/year), education into 3
(< 13, 13-14, and ≥ 15 years; these levels are equivalent
to high school, junior college or vocational/technical
school, and university or more, respectively), smoking
history into 3 (never, former, and current), pack-years of
smoking into 3 (none, 0.05-3.9, and ≥ 4.0), and lifetime
ETS exposure into 4 (never, only at home, only at work,
and both at home and at work). Age was used as a con-
tinuous variable. Multiple logistic regression analysis
was performed to estimate adjusted odds ratios (ORs)
and 95% confidence intervals (CIs) of allergic disorders
relative to smoking status. Trend of association was
assessed by a logistic regression model assigning conse-
cutive integers to the categories of the exposure vari-
ables. All statistical analyses were performed using the
SAS software package version 9.2 (SAS Institute, Inc.,
Cary, NC, USA).
Results
The prevalence values of wheeze, asthma, eczema, and
rhinoconjunctivitis in the past 12 months were 10.4%,
5.5%, 13.0%, and 25.9%, respectively, among the 1743
pregnant women. Characteristics of the study subjects
are described in Table 1. The mean age of the partici-
p a n t sa tb a s e l i n ew e r e3 1 . 2y e a r s .M a n ym o r ep a r t i c i -
pants had a family history of allergic rhinitis than a
family history of asthma or atopic eczema.
The prevalence of allergic diseases according to smok-
i n gs t a t u si sp r o v i d e di nT a b l e2 .T h e r ei sas t e p w i s e
increase in the prevalence of wheeze and asthma in rela-
tion to smoking status; prevalence is highest among cur-
rent smokers. Table 3 presents the prevalence of allergic
diseases according to ETS exposure status among 1182
pregnant women who had never smoked. For all allergic
diseases, the highest prevalence was observed in women
who were exposed to ETS both at home and at work;
the prevalence values of wheeze, asthma, eczema, and
rhinoconjunctivitis among women in this category were
11.6%, 6.6%, 13.3%, and 28.2%, respectively.
Table 4 shows ORs and 95% CIs for allergic disorders
in relation to smoking status. Compared with never
smoking, current smoking was positively associated with
t h ep r e v a l e n c eo fw h e e z e :a d j u s t e dO Rw a s1 . 5 2( 9 5 %
CI: 1.05 to 2.12). There was no statistically significant
association between former smoking and the prevalence
of wheeze. Compared with never smoking, ≥ 4 pack-
years of smoking was significantly positively associated
with wheeze, showing a clear dose-response relationship
with the cumulative consumption of cigarettes (P for
linear trend = 0.002). There were no associations
between smoking status and the prevalence of asthma,
eczema, or rhinoconjunctivitis.
Table 5 shows the association between exposure to
ETS and allergic disorders among the 1182 subjects who
had never smoked. When the subjects who had never
smoked were classified into four mutually exclusive
categories based on the source of ETS exposure (never,
only at home, only at work, and both), exposure to ETS
both at home and at work was independently associated
with a 2.7-fold increased prevalence of wheeze (adjusted
OR = 2.73, 95% CI: 1.37 to 6.08), while no association
was observed between exposure to ETS only at home or
only at work and wheeze. Exposure to ETS only at
home and exposure to ETS both at home and at work
were independently positively associated with rhinocon-
junctivitis: adjusted ORs for only at home and for both
at home and at work were 1.63 (95% CI: 1.05 to 2.57)
and 1.69 (95% CI: 1.12 to 2.59), respectively. The asso-
ciation between exposure to ETS only at work and the
prevalence of rhinoconjunctivitis was not significant.
Table 1 Distribution of selected characteristics in 1743
pregnant women, Kyushu Okinawa Maternal and Child
Health Study, Japan
Variable No. (%) or mean ± SD
Age, years, mean ± SD 31.2 ± 4.4
Region of residence, %
Fukuoka Prefecture 970 (55.7)
Other than Fukuoka Prefecture in Kyushu 591 (33.9)
Okinawa Prefecture 182 (10.4)
Family history of asthma, % 330 (18.9)
Family history of atopic eczema, % 302 (17.3)
Family history of allergic rhinitis, % 759 (43.6)
Household income, %, yen/year
< 4,000,000 632 (36.3)
4,000,000 - 5,999,999 618 (35.5)
≥ 6,000,000 493 (28.3)
Education, %, years
< 13 428 (24.6)
13 - 14 576 (33.1)
≥ 15 739 (42.4)
Smoking status, %
Never 1182 (67.8)
Former 503 (28.9)
Current 58 (3.3)
Pack-years of smoking, %
None 1182 (67.8)
0.05 - 3.9 262 (15.0)
≥ 4.0 299 (17.2)
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and the prevalence of asthma or eczema.
Discussion
In this study, we found that current smoking and ≥ 4
pack-years of smoking were independently positively
related to wheeze. These findings are in accordance
with results from previous cross-sectional studies that
reported a positive association between ever smoking
and the prevalence of wheeze in adults [12,18]. A popu-
lation-based cross-sectional study in Denmark showed a
significantly positive dose-response relationship between
the amount of tobacco used per day and the prevalence
of wheeze [18]. In a cross-sectional study among male
farmers, current smoking was associated with an
increased prevalence of wheeze [12]. Between asthma
and smoking status, on the other hand, we found no
association. The relationship between smoking status
and asthma in adults remains controversial because the
results of previous studies have been inconclusive; some
studies have found an increased risk of asthma in rela-
tion to smoking [2-5], and others have failed to find
such a correlation [2,6]. In a population-based cohort
study among men in Japan, current smokers at baseline
had a significantly increased risk of asthma compared
with those who had never smoked, though no such sta-
tistically significant association was observed among
women [2]. A cross-sectional study of pregnant Japanese
women showed that current smoking was associated
with an increased prevalence of asthma after the age of
18 years [4]. In a US cross-sectional study, former
smoking was positively associated with the prevalence of
asthma among males, whereas no association was
observed between current smoking and the prevalence
of asthma [6]. Among females in the same study, how-
ever, there was no association between former or cur-
rent smoking and the prevalence of asthma [6].
The lack of association between smoking status and
asthma observed in the present study might be
explained by the “healthy smoker effect” [28,29]. Current
smoking might be associated with better health, as heal-
thier individuals are better able to tolerate the negative
health effects of smoking. Thus, current smokers may
be less likely to have or develop asthma. Moreover, the
fact that there were only 38 females with asthma who
had ever smoked in our study might have led to low sta-
tistical power for detecting a possible association
between ever smoking and asthma.
Previous studies on smoking and eczema and/or rhi-
noconjunctivitis in adults have been limited and have
provided contradictory results. Our results regarding
eczema are in agreement with those of a previously
cited Japanese cross-sectional study demonstrating no
association between cigarette smoking and atopic
eczema [4]. A case-control study in Taiwan, in contrast,
found that smoking was associated with increased risk
of adult-onset atopic eczema [11]. No association
between smoking status and rhinoconjunctivitis was
Table 2 Prevalence of allergic disorders according to smoking status in 1743 pregnant women, Kyushu Okinawa
Maternal and Child Health Study, Japan
Wheeze Asthma Eczema Rhinoconjunctivitis
Nn%n%n% n %
Smoking status
Never 1182 105 8.9% 58 4.9% 146 12.4% 302 25.6%
Former 503 65 12.9% 31 6.2% 72 14.3% 133 26.4%
Current 58 12 20.7% 7 12.1% 8 13.8% 17 29.3%
Pack-years of smoking
None 1182 105 8.9% 58 4.9% 146 12.4% 302 25.6%
0.05-3.9 262 27 10.3% 11 4.2% 36 13.7% 68 26.0%
≥ 4.0 299 50 16.7% 27 9.0% 44 14.7% 82 27.4%
Table 3 Prevalence of allergic disorders according to ETS exposure status in 1182 pregnant women who had never
smoked, Kyushu Okinawa Maternal and Child Health Study, Japan
Wheeze Asthma Eczema Rhinoconjunctivitis
Nn % n % n % n %
Lifetime ETS exposure at home or at work
Never 189 9 4.8% 6 3.2% 18 9.5% 37 19.6%
Only at home 313 26 8.3% 11 3.5% 39 12.5% 85 27.2%
Only at work 162 10 6.2% 7 4.3% 20 12.4% 34 21.0%
Both 518 60 11.6% 34 6.6% 69 13.3% 146 28.2%
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also been reached in some previous studies [4,10], while
other previous studies have observed inverse associa-
tions between smoking and rhinitis, hay fever, or cedar
pollinosis [7-9]. It should be noted that the various stu-
dies mentioned here have used different definitions of
outcomes, study populations and designs, smoking
exposure assessment methods, and confounding factors,
thus limiting the feasibility of inter-study comparisons.
In keeping with other previous studies [14,15,17,18],
w ef o u n dt h a tE T Se x p o s u r ew a sa s s o c i a t e dw i t ha n
increased prevalence of wheeze. A cross-sectional study
in Denmark has shown that daily ETS exposure for 5 or
more hours is positively associated with the prevalence
of wheeze among those who had never smoked [18]. A
positive association between exposure to ETS and the
prevalence of positive history of wheezing was found
among male police officers in Hong Kong [15]. In con-
trast, a prospective study of subjects aged 15 to 40 years
of age who had never smoked showed no association
between ETS exposure and the risk of wheeze [13].
In our study, we found that the positive association
between wheeze and exposure to ETS was more evident
when exposure occurred at home rather than at work. A
cross-sectional study among Italian women who had
never smoked, on the other hand, revealed that ETS
exposure at work was significantly positively associated
with wheeze, whereas there was no association between
wheeze and exposure to ETS due to their husbands’
smoking [14]. A cross-sectional study performed in Fin-
land, Estonia, and Sweden also showed a significant
positive association between ETS exposure outside of
the home, but not at home, and the prevalence of
wheeze [17]. These results are at variance with our find-
ings. In Japan, a law that restricts smoking in public
places came into effect in 2004. Since then, awareness
about the effects of ETS has been increasing, and many
workplaces now have smoking restrictions or bans. In
Table 4 Crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for allergic disorders according to
smoking status in 1743 pregnant women, Kyushu Okinawa Maternal and Child Health Study, Japan
Wheeze Asthma Eczema Rhinoconjunctivitis
Crude OR
(95% CI)
Adjusted OR
1
(95% CI)
Crude OR
(95% CI)
Adjusted OR
1
(95% CI)
Crude OR
(95% CI)
Adjusted OR
1
(95% CI)
Crude OR
(95% CI)
Adjusted OR
1
(95% CI)
Smoking status
Never 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Former 1.52
(1.09-2.11)
1.39
(0.98-1.95)
1.27
(0.80-1.98)
1.07
(0.66-1.70)
1.19
(0.87-1.60)
1.16
(0.84-1.58)
1.05
(0.83-1.33)
0.99
(0.77-1.27)
Current 1.64
(1.15-2.25)
1.52
(1.05-2.12)
1.63
(1.03-2.40)
1.40
(0.87-2.10)
1.07
(0.70-1.52)
0.98
(0.64-1.42)
1.10
(0.81-1.46)
1.05 (0.77-1.41)
Pack-years of smoking
None 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
0.05-3.9 1.18
(0.74-1.82)
1.03
(0.64-1.61)
0.85
(0.42-1.58)
0.71
(0.34-1.34)
1.13
(0.75-1.66)
1.02
(0.67-1.52)
1.02
(0.75-1.38)
0.92
(0.67-1.25)
≥ 4.0 2.06
(1.42-2.95)
1.93
(1.30-2.83)
1.92
(1.18-3.07)
1.58
(0.94-2.58)
1.22
(0.84-1.75)
1.25
(0.85-1.82)
1.10
(0.82-1.46)
1.08
(0.80-1.46)
P for trend 0.0002 0.002 0.02 0.15 0.25 0.29 0.52 0.75
1 Adjustment for age; region of residence; family history of asthma, atopic eczema, and allergic rhinitis; household income; and education
Table 5 Crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for allergic disorders according to
ETS exposure status in 1182 pregnant women who had never smoked, Kyushu Okinawa Maternal and Child Health
Study, Japan
Wheeze Asthma Eczema Rhinoconjunctivitis
Crude OR
(95% CI)
Adjusted OR
1
(95% CI)
Crude OR
(95% CI)
Adjusted OR
1
(95% CI)
Crude OR
(95% CI)
Adjusted OR
1
(95% CI)
Crude OR
(95% CI)
Adjusted OR
1
(95% CI)
Lifetime ETS exposure at home or at work
Never 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Only at home 1.81
(0.86-4.17)
1.83
(0.86-4.25)
1.11
(0.42-3.27)
1.08
(0.40-3.20)
1.35
(0.76-2.49)
1.39
(0.77-2.59)
1.53
(1.00-2.39)
1.63
(1.05-2.57)
Only at work 1.32
(0.52-3.39)
1.24
(0.48-3.25)
1.38
(0.45-4.36)
1.18
(0.38-3.79)
1.34
(0.68-2.65)
1.29
(0.65-2.60)
1.09
(0.65-1.84)
1.10
(0.64-1.88)
Both 2.62
(1.34-5.76)
2.73
(1.37-6.08)
2.14
(0.95-5.75)
1.96
(0.85-5.34)
1.46
(0.86-2.59)
1.55
(0.90-2.80)
1.61
(1.08-2.45)
1.69
(1.12-2.59)
1 Adjustment for age; region of residence; family history of asthma, atopic eczema, and allergic rhinitis; household income; and education
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becoming less common. In the present study, exposure
to ETS both at home and at work yielded a higher OR
for wheeze than did exposure in only one location. Sub-
jects who are exposed in both places are likely to receive
a higher level of ETS exposure compared to those who
are exposed in only one place.
A limited number of studies have addressed the effect
of ETS exposure on asthma in adults [14,16,17]. A
population-based incident case-control study in Finland
found that both workplace and home ETS exposure
during the past 12 months were significantly related to
an increased risk of new development of asthma in 21-
to 63-year-old adults [16]. A significant positive associa-
tion between ETS exposure and asthma has also been
reported in other cross-sectional studies [14,17]. In con-
trast, our results failed to reveal a positive association
between ETS exposure and asthma. This may be due to
a tendency among patients with asthma to voluntarily
avoid exposure to ETS. Also, family members in a
household that includes persons with asthma and cow-
orkers of persons with asthma may be more likely to
stop or curtail their smoking. In addition, it may be dif-
ficult to detect a clear positive association between ETS
exposure and asthma in a population containing few
patients with asthma.
To our knowledge, there have been two epidemiologi-
cal studies addressing the association between ETS
exposure and eczema in adults [4,11]. A case-control
study in Taiwan showed that exposure to ETS at home
prior to 20 years of age was positively associated with
an increased risk of adult-onset atopic eczema among
persons who had never smoked. A previously cited
cross-sectional study among pregnant Japanese women
found no association between ETS exposure at home or
at work and the prevalence of eczema [4]. The findings
of the latter study are in agreement with our own.
We found that exposure to ETS only at home and
both at home and at work, but not only at work, was
associated with an increased prevalence of rhinocon-
junctivitis. Consistent with our results, several previously
mentioned cross-sectional studies have found positive
associations between ETS exposure and rhinoconjuncti-
vitis [4,14] or rhinitis symptoms [8]. A cross-sectional
study among Italian women who had never smoked
showed a positive association between exposure to
smoke from their husbands’ smoking and rhinoconjunc-
tivitis; this association was more evident than the rela-
tionship between ETS at work and rhinoconjunctivitis
[14]. Our results were at variance with those of other
studies that have found no association between ETS
exposure and rhinitis [20,21].
This study had certain methodological strengths. Study
subjects were homogeneous in that all were pregnant,
which likely reduces the potential for confounding result-
ing from unmeasured factors related to pregnancy. Defi-
nitions of wheeze and asthma were based on the
questions in the European Community Respiratory
Health Survey. The prevalence values for eczema and rhi-
noconjunctivitis were estimated based on the questions
in the International Study of Asthma and Allergies in
Childhood, although validation tests for these questions
have not been performed for Japanese adults. Using a
standardized methodology allows for comparisons with
results from other epidemiological studies using the same
methodology. Potential confounders were adjusted for
with extensive data. However, it is possible that our
results remain confounded by other potentially important
factors, such as aeroallergens and air pollution.
There were certain limitations of this study as well.
The participation rate could not be calculated because
the exact number of eligible pregnant women who were
provided with a set of leaflets explaining the KOMCHS,
an application form, and a self-addressed and stamped
return envelope by the 423 collaborating obstetric hospi-
tals is not available. We were not able to assess the dif-
ferences between participants and non-participants,
because information on personal characteristics such as
age, socioeconomic status, and history of allergic disor-
ders among non-participants is not available. Our sub-
j e c t sw e r ep r o b a b l yn o tar e p r e s e n t a t i v es a m p l eo f
Japanese women in the general population, given that all
were pregnant women. In addition, educational levels in
the current study population were higher than in the
general population. According to the 2000 population
census of Japan, the proportions of women aged 30 to
34 years in Fukuoka Prefecture with < 13, 13-14, ≥ 15,
and an unknown number of years of education were
52.0%, 31.5%, 11.8%, and 4.8%, respectively [30]. The
corresponding figures for the current study were 24.6%,
33.1%, 42.4%, and 0.0%, respectively. The present popu-
lation might therefore have had a greater awareness
about health than the general population. Nevertheless,
cigarette-smoking status in our study population was
likely to be similar to that in the general population. In
the National Health and Nutrition Survey in Japan in
2007, the percentages of currently-smoking, formerly-
smoking, and non-smoking women aged 30 to 39 years
were 17.2%, 11.4%, and 71.4%, respectively, although
data specific to pregnant women were not available [31].
The corresponding figures for the present subjects were
3.3%, 28.9%, and 67.8%, respectively. Many of the preg-
nant women in the current study may have given up
smoking upon becoming pregnant, thus increasing the
percentage of former smokers.
Other limitations may also have influenced the inter-
pretation of the current results. As this study is cross-
sectional, the temporal nature of the association
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diseases could not be examined. Assessment of exposure
was based on the subjects’ questionnaire responses and
was not validated by objective measurements, such as
salivary, serum, or hair cotinine levels. Using question-
naires may result in misclassification due to recall bias.
If present, however, this bias would tend to reduce the
observed association between smoking and allergic dis-
eases. We did not measure exposure to ETS at social
settings outside the home and work. Given the difficul-
ties in accurately measuring ETS exposure, the associa-
tion between ETS exposure and allergic diseases
observed here is likely to be an underestimate.
The interface between allergy/immunology and preg-
n a n c ys h o u l db ed i s c u s s e d ,a si tm a yh a v ea ni n f l u e n c e
on the association of interest. It has been suggested that
pregnancy involves a shift to the Th2 side of the
immune response [32], although Chaouat et al. have
pointed out the importance of the role of natural killer
cells and IL-12, IL-15, and IL-18 tripods in successful or
failed pregnancies in humans beyond the Th1/Th2 para-
digm [33]. The hormonal changes in pregnancy are
often invoked to explain the apparent association
between rhinitis symptoms and pregnancy. However,
rhinitis ascribed solely to pregnancy may not be a dis-
tinct entity because most pregnant women do not have
significant nasal symptoms [32].
Conclusions
Current smoking and ≥ 4 pack-years of smoking were
significantly associated with increased prevalence of
wheeze, but not of asthma, eczema, or rhinoconjunctivi-
tis, among pregnant Japanese women. Positive associa-
tions between exposure to ETS and the prevalence of
wheeze and that of rhinoconjunctivitis were found in
subjects who had never smoked.
Even though more evidence is needed to validate the
association between smoking exposure and allergic dis-
eases in adults, there are limited studies which have
focused on this association. This study provides valuable
evidence regarding the association between smoking
exposure and allergic diseases in adults. To clarify the
associations between current or former smoking or ETS
exposure and allergic diseases among adults, further stu-
dies with longitudinal design and more precise measure-
ments of exposure, such as salivary, serum, or hair
cotinine levels, will be needed. A follow-up survey of the
KOMCHS will allow us to establish whether smoking
exposure is an important predictor of allergic disorders
in adulthood.
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